Phase 0/I/II Cancer Prevention Clinical Trials Program Clinical Trials

Titlesort descending Intervention NCT ID Sponsor Status
Defined Green Tea Catechin Extract in Preventing Liver Cancer in Patients With Cirrhosis Defined Green Tea Catechin Extract, Laboratory Biomarker Analysis, Pharmacological Study, Questionnaire Administration NCT03278925 National Cancer Institute (NCI) Recruiting
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection DNA Plasmid Encoding Interleukin-12 INO-9012, Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, Laboratory Biomarker Analysis, Quality-of-Life Assessment NCT02772003 National Cancer Institute (NCI) Recruiting
Dolcanatide in Preventing Colorectal Cancer in Healthy Volunteers Laboratory Biomarker Analysis, Placebo, Questionnaire Administration, Dolcanatide NCT03300570 National Cancer Institute (NCI) Active, not recruiting
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver Erlotinib, Erlotinib Hydrochloride, Laboratory Biomarker Analysis, Quality-of-Life Assessment NCT02273362 National Cancer Institute (NCI) Recruiting
Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous... Erlotinib, Erlotinib Hydrochloride NCT02961374 National Cancer Institute (NCI) Active, not recruiting
Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial... Pharmacokinetic Study, Exemestane, Laboratory Biomarker Analysis, Questionnaire Administration NCT03300557 National Cancer Institute (NCI) Recruiting
Iloprost in Preventing Lung Cancer in Former Smokers Iloprost, Placebo, Quality-of-Life Assessment, Questionnaire Administration NCT02237183 National Cancer Institute (NCI) Recruiting
Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion Laboratory Biomarker Analysis, Metformin Hydrochloride NCT02581137 National Cancer Institute (NCI) Active, not recruiting
Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer Laboratory Biomarker Analysis, Nelipepimut-S Plus GM-CSF Vaccine, Sargramostim NCT02636582 National Cancer Institute (NCI) Active, not recruiting
Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery Placebo, Questionnaire Administration, Z-Endoxifen Hydrochloride NCT03317405 National Cancer Institute (NCI) Recruiting

Pages